Document is current

Any future updates will be listed below

512 Time-of-day of pembrolizumab infusion and clinical outcomes of patients with NSCLC: too soon to promote morning infusions

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0512

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark